222 related articles for article (PubMed ID: 25268213)
41. Cancer epigenetics as biomarkers of clinical significance.
Panayiotidis MI
Cancer Lett; 2014 Jan; 342(2):168-9. PubMed ID: 24183850
[No Abstract] [Full Text] [Related]
42. [Familial clustering, genetic roots and insights into the pathogenesis of autoimmune diseases].
Pierer M; Baerwald C; Wagner U
Z Rheumatol; 2009 Nov; 68(9):758-62. PubMed ID: 19838714
[TBL] [Abstract][Full Text] [Related]
43. [Genetic risk profile of sarcoidosis].
Fischer A; Zissel G; Nebel A; Müller-Quernheim J
Internist (Berl); 2014 Feb; 55(2):135-40. PubMed ID: 24217528
[TBL] [Abstract][Full Text] [Related]
44. Variations in the APP gene promoter region and risk of Alzheimer disease.
Guyant-Maréchal L; Rovelet-Lecrux A; Goumidi L; Cousin E; Hannequin D; Raux G; Penet C; Ricard S; Macé S; Amouyel P; Deleuze JF; Frebourg T; Brice A; Lambert JC; Campion D
Neurology; 2007 Feb; 68(9):684-7. PubMed ID: 17325276
[TBL] [Abstract][Full Text] [Related]
45. Heart failure: advanced development in genetics and epigenetics.
Yang J; Xu WW; Hu SJ
Biomed Res Int; 2015; 2015():352734. PubMed ID: 25949994
[TBL] [Abstract][Full Text] [Related]
46. Genome studies: genetics by numbers.
Baker M
Nature; 2008 Jan; 451(7178):516-8. PubMed ID: 18235474
[No Abstract] [Full Text] [Related]
47. Single nucleotide polymorphism analysis in the human phosphatase PTPrj gene using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.
Powell N; Dudley E; Morishita M; Bogdanova T; Tronko M; Thomas G
Rapid Commun Mass Spectrom; 2004; 18(19):2249-54. PubMed ID: 15384144
[TBL] [Abstract][Full Text] [Related]
48. What is the role of molecular markers in the management of "indeterminate" thyroid nodules?
Daniels GH
Cancer Cytopathol; 2013 May; 121(5):223-4. PubMed ID: 23670834
[No Abstract] [Full Text] [Related]
49. THADA gene polymorphism and prostate cancer risk: a meta-analysis.
Zhao F; Xu Y; Yang K; Liu M; Wei D; Zhang Y; Shi X; Yang F; Wang X; Liang S; Zhao C; Chen X; Sun L; Zhu X; Wang N; Hui J; Zhang Y; Zhu L; Yang Y; Tang L; Wang J; Yang Z
Oncol Res Treat; 2014; 37(3):106-10. PubMed ID: 24685913
[TBL] [Abstract][Full Text] [Related]
50. [Genodermatoses].
Happle R; Traupe H
Hautarzt; 2011 Feb; 62(2):80-1. PubMed ID: 21312019
[No Abstract] [Full Text] [Related]
51. Parallel optimization and genotyping of multiple single-nucleotide polymorphism markers by sample pooling approach using cycling-gradient CE with multiple injections.
Minarik M; Benesova L; Fantova L; Horacek J; Heracek J; Loukola A
Electrophoresis; 2006 Oct; 27(19):3856-63. PubMed ID: 16972303
[TBL] [Abstract][Full Text] [Related]
52. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
53. Five genetic variants associated with prostate cancer.
Gartner CE; Barendregt JJ; Hall WD
N Engl J Med; 2008 Jun; 358(25):2738-9; author reply 2741. PubMed ID: 18572445
[No Abstract] [Full Text] [Related]
54. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.
Lee Y; Yoon KA; Joo J; Lee D; Bae K; Han JY; Lee JS
Carcinogenesis; 2013 Feb; 34(2):307-13. PubMed ID: 23144319
[TBL] [Abstract][Full Text] [Related]
55. Personalized cancer diagnostics and therapeutics.
Roukos DH
Expert Rev Mol Diagn; 2009 Apr; 9(3):227-9. PubMed ID: 19379081
[No Abstract] [Full Text] [Related]
56. [Genetic testing and gene-based testing for type 2 diabetes].
Osawa H; Onuma H; Makino H
Nihon Rinsho; 2005 Dec; 63 Suppl 12():295-300. PubMed ID: 16416811
[No Abstract] [Full Text] [Related]
57. Integrating next-generation sequencing into the diagnostic testing of inherited cancer predisposition.
Ku CS; Cooper DN; Iacopetta B; Roukos DH
Clin Genet; 2013 Jan; 83(1):2-6. PubMed ID: 23020236
[TBL] [Abstract][Full Text] [Related]
58. [Molecular targeted cancer therapy and genetic tests --chairman's introductory remarks].
Hinoda Y
Rinsho Byori; 2012 Oct; 60(10):967-8. PubMed ID: 23323461
[TBL] [Abstract][Full Text] [Related]
59. Assessing both genetic variation (SNPs/CNVs) and gene-environment interactions may lead to personalized gastric cancer prevention.
Roukos DH
Expert Rev Mol Diagn; 2009 Jan; 9(1):1-6. PubMed ID: 19099341
[No Abstract] [Full Text] [Related]
60. [Precision Oncology: Approaching the Target].
Hiddemann W
Dtsch Med Wochenschr; 2017 Nov; 142(22):1637. PubMed ID: 29078208
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
